EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Dysfunction and Metabolic Reprogramming in Obesity and Asthma

Paige Hartsoe, Fernando Holguin, Hong Wei Chu

International Journal of Molecular Sciences · 03.03.2024 · 25 (5) · 2944

DOI: 10.3390/ijms25052944 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.03.2024. Verfasst von Paige Hartsoe und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, National Jewish Health, Denver, CO 80222, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Asthma, Mitochondrial Diseases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction and metabolic reprogramming have been extensively studied in many disorders ranging from cardiovascular to neurodegenerative disease. Obesity has previously been associated with mitochondrial fragmentation, dysregulated glycolysis, and oxidative phosphorylation, as well as increased reactive oxygen species production. Current treatments focus on reducing cellular stress to restore homeostasis through the use of antioxidants or alterations of mitochondrial dynamics. This review focuses on the role of mitochondrial dysfunction in obesity particularly for those suffering from asthma and examines mitochondrial transfer from mesenchymal stem cells to restore function as a potential therapy. Mitochondrial targeted therapy to restore healthy metabolism may provide a unique approach to alleviate dysregulation in individuals with this unique endotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAsthmaMitochondrial DiseasesHumansOxidative StressMetabolic ReprogrammingObesityReactive Oxygen Species

Stichwörter der Autor:innen

asthmainflammationmesenchymal stem cellsmetabolic reprogrammingmitochondrial dysfunctionobesityreactive oxygen species

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Medicine, National Jewish Health, Denver, CO 80222, USA.
  • Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Hartsoe, P., Holguin, F., & Chu, H. W. (2024). Mitochondrial Dysfunction and Metabolic Reprogramming in Obesity and Asthma. International Journal of Molecular Sciences, 25(5), 2944. https://doi.org/10.3390/ijms25052944

Vancouver

Hartsoe P, Holguin F, Chu HW. Mitochondrial Dysfunction and Metabolic Reprogramming in Obesity and Asthma. International Journal of Molecular Sciences. 2024;25(5):2944. doi:10.3390/ijms25052944

BibTeX
@article{Hartsoe2024,
  author = {Hartsoe, Paige and Holguin, Fernando and Chu, Hong Wei},
  title = {Mitochondrial Dysfunction and Metabolic Reprogramming in Obesity and Asthma},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {5},
  pages = {2944},
  doi = {10.3390/ijms25052944}
}
Kostenlos starten →